Physician profile
William M George
NPI 1558354076
$2,666.12
in general payments reported to CMS, 2019-2025
30 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $272 · 2021: $429 · 2022: $502 · 2023: $461 · 2024: $248 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $715.81 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $464.70 | 2019-2024 | |
| Novo Nordisk INC | $372.60 | 2020-2024 | Wegovy, Saxenda |
| Amgen INC. | $311.29 | 2019-2025 | Evenity |
| Biohaven Pharmaceutical Holding Company LTD. | $87.97 | 2022 | |
| Abbott Laboratories | $58.85 | 2022-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Hologic Sales and Service, LLC | $54.11 | 2023 | Aptima, Panther Fusion |
| Lilly USA, LLC | $52.98 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $51.55 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ultragenyx Pharmaceutical INC. | $51.55 | 2022-2023 | |
| Pfizer INC. | $50.51 | 2024-2025 | |
| Eisai INC. | $41.40 | 2020-2021 | |
| Allergan, INC. | $31.81 | 2019-2021 | |
| Rhythm Pharmaceuticals, INC. | $31.40 | 2025 | Imcivree |
| Medtronic, INC. | $30.45 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $27.59 | 2019-2024 | Tymlos |
| Cepheid | $22.23 | 2023 | Genexpert |
| Bayer Healthcare Pharmaceuticals INC. | $21.11 | 2024 | |
| Scilex Pharmaceuticals INC. | $20.28 | 2023 | Ztlido |
| Exact Sciences Corporation | $18.95 | 2025 | The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $18.63 | 2021 | |
| Dexcom, INC. | $16.47 | 2024 | Dexcom G6 Transmitter |
| Almatica Pharma LLC | $16.42 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.45 | 2021 | |
| Coopersurgical, INC. | $15.05 | 2021 | |
| Urovant Sciences INC | $14.61 | 2022 | |
| Boston Scientific Corporation | $14.56 | 2020 | |
| Irhythm Technologies, INC. | $12.96 | 2023 | Zio Xt Patch |
| Teva Pharmaceuticals USA, INC. | $12.56 | 2019 | |
| Valeritas, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.